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Abstract: Multidetector-row computed tomography (MDCT) can be used to quantify morphological 
features and investigate structure/function relationship in COPD. This approach allows a phenotypi-
cal deﬁ  nition of COPD patients, and might improve our understanding of disease pathogenesis and 
suggest new therapeutical options. In recent years, magnetic resonance imaging (MRI) has also 
become potentially suitable for the assessment of ventilation, perfusion and respiratory mechanics. 
This review focuses on the established clinical applications of CT, and novel CT and MRI techniques, 
which may prove valuable in evaluating the structural and functional damage in COPD.
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Introduction
Chronic obstructive pulmonary disease (COPD), which encompasses both chronic bronchi-
tis and emphysema, is one of the commonest respiratory conditions of adults in the developed 
world. Despite being deﬁ  ned by the presence of abnormal pulmonary function, namely a 
largely irreversible airﬂ  ow obstruction, COPD patients also exhibit speciﬁ  c morphologic 
changes in the central and peripheral airways, lung parenchyma, and pulmonary vascula-
ture. Those changes are well depicted by computed tomography (CT), whereas magnetic 
resonance imaging (MRI) has brought a new dimension to studies of COPD. Both techniques 
have much improved our understanding of the pathophysiology of this disorder.
CT indices of emphysema reﬂ  ect lung anatomy and represent the best way to assess 
emphysema severity in life (Newell et al 2004). The introduction of multidetector-row 
CT (MDCT) scanners has provided powerful tools to evaluate changes in both small 
and large airways. In addition, dynamic imaging via MDCT allows the assessment of 
perfusion and ventilation in the lung parenchyma. Therefore, CT is able to precisely 
deﬁ  ne the pathological process by providing accurate anatomic informations as well 
as functional data from the area of interest.
The increasing interest in the deﬁ  nition of the functional damage in COPD patients 
has also motivated investigation in MRI. Improved imaging protocols are now available 
on every MR system for the morphologic evaluation of the lung. Several investiga-
tors have also demonstrated that, within the same examination, MRI has potentials to 
provide clinically relevant information on lung function.
This review focuses on the deﬁ  nition by CT of a number of different phenotypes 
observed in COPD. In addition, it summarizes the main CT quantiﬁ  cation systems of 
morphological abnormalities and the potential role of CT in evaluating COPD-related 
functional abnormalities. Finally, it presents an overview of some of the recent MR 
techniques for measuring lung function, which in future might become routinely 
available for the assessment of COPD patients.
COPD phenotypes according
to CT ﬁ  ndings: a practical approach
Although the diagnostic criteria established by the Global Strategy for the Diagnosis, 
Management and Prevention of Chronic Obstructive Lung Disease (GOLD [Global International Journal of COPD 2007:2(3) 302
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Initiative for Chronic Obstructive Lung Disease]) do not 
currently include CT ﬁ  ndings (Pauwels et al 2001), a consistent 
body of literature suggests that CT represents an important 
tool in the clinical setting. COPD in primary care is a het-
erogeneous condition (O’Brien et al 2000) and the challenge 
for the clinicians is to identify what causes the airﬂ  ow limita-
tion and to separate reversible from irreversible components 
of such limitation. In this regard, CT can reveal what both 
clinical examinations and pulmonary function tests (PFTs) 
often cannot, namely the lesions that may mimic COPD and 
the predominance as well as the interplay between emphysema 
and airways disease.
A broad spectrum of disorders, including bronchiectasis, 
upper airway lesions, bronchiolar diseases, and interstitial 
lung diseases, are often associated with chronic airﬂ  ow 
obstruction. CT, and in particular HRCT, can discriminate 
between different causes of airﬂ  ow obstruction. In order 
to assess the diagnostic utility of HRCT in diagnosing 
COPD, Kurashima et al (2005) showed in a cohort of 516 
consecutive patients whose FEV1/FVC was less than 70% 
after inhalation of bronchodilator, that HRCT was essential 
in revealing that 12.7% of them had pulmonary diseases 
other COPD, including sarcoidosis, diffuse panbronchiolitis 
and pneumoconiosis. Undoubtedly, a better characterization 
of the underlying disease is crucial in order to reduce the 
variability of response to treatment in COPD patients. The 
variable proportion of emphysema, bronchial wall thickening 
and air-trapping – all common features of COPD – can be 
morphologically characterized by HRCT.
HRCT scan may reveal evidence of pulmonary emphy-
sema even in asymptomatic smokers with a normal lung 
function. Recent data from our laboratory on 43 cases clas-
siﬁ  ed according to the GOLD criteria, demonstrated that 
13/18 subjects with Stage 0 had emphysema on HRCT. 
Although it has been demonstrated that in patients with stage 
0 symptoms of chronic bronchitis do not increase the risk 
of progression in COPD, no longitudinal study has clariﬁ  ed 
the role of emphysema at that stage. Recent studies highlight 
the importance of identifying and quantifying emphysema 
in patients with COPD as the emphysematous phenotype 
is associated with more severe disease (Boschetto et al 
2003, 2006). COPD patients with emphysema on HRCT 
display an higher BODE index (body mass index, airﬂ  ow 
obstruction, dyspnoea, exercise performance) and a lower 
inspiratory capacity to total lung capacity ratio (IC/TLC) 
than those without emphysema, suggesting a more important 
systemic involvement in emphysematous patients (Boschetto 
et al 2006a). Nevertheless, it has been also shown that the 
distribution of emphysema on CT predicts mortality, with an 
improved survival in patients with more extensive emphy-
sema in the upper zones compared with the lower zones of 
the lung (Martinez et al 2006). The authors speculated that 
lower-lobe emphysema may be either a marker of increased 
disease severity or, alternatively, a phenotypic or patho-
biologic variant (Martinez et al 2006). However, the same 
authors suggested that their ﬁ  ndings may not be applicable to 
all patients with COPD, since their subjects were part of the 
National Emphysema Treatment Trial (NETT), and exhibited 
speciﬁ  c features (Martinez et al 2006).
Emphysema and airway-related COPD are distinct 
phenotypes and have different relationships with smoking 
(Patel et al 2006). Airway and parenchymal phenotypes show 
familial concordance. Moreover, differences in the extent 
of emphysema are not explained by cumulative smoking, 
suggesting a complex gene–environment interaction (Patel 
et al 2006). The ability to separate airway-predominant 
from parenchymal-predominant pathology in COPD may 
prove useful in applying speciﬁ  c therapies designed to 
prevent airway remodelling and parenchymal destruction 
(Grenier 2005). Measurements of lung physiology do not 
always discriminate between the abnormalities resulting 
from predominant emphysema from those resulting from 
predominant small airways disease. As discussed later, 
advances in quantitative CT scanning have the potential 
separate and quantify both emphysema and airway 
component in COPD patients. However, a simple visual 
assessment may already provide important informations. 
Despite an inherent subjectivity in the visual evaluation, 
many variables (particularly the analysis of lung texture) do 
not lend themselves to quantiﬁ  cation using usual automated 
methods. The insight that some patients given the label of 
COPD have “pure” airways diseases or emphysema has been 
provided by HRCT. Furthermore, “naked eye” has additional 
advantages in detecting heterogeneity and co-morbidities 
on HRCT scans of COPD patients. Radiologists can often 
distinguish between a smoking disease phenotype (usually 
characterized by centrilobular emphysema) and lesions 
associated with alpha1-proteinase inhibitor (α1-antitrypsin) 
deficiency (Figures 1 and 2). In addition, HRCT can 
suggest the coexistence of panlobular and centrilobular 
emphysema in the same individual, as some patients with 
α1-antitrypsin deﬁ  ciency are also smokers (Copley et al 
2002). Nevertheless, it should be also appreciated that the 
lung surrounding the emphysematous lesions does not always 
appear normal as smoking-induced inﬁ  ltrative lung diseases 
may coexist (Hansell et al 2005).International Journal of COPD 2007:2(3) 303
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It has been recently shown that COPD patients with 
chronic bronchitis display an increased bronchial wall 
thickening compared to patients without chronic bronchitis 
(Orlandi et al 2005). Despite being a non speciﬁ  c sign, it 
looks worth relating bronchial wall thickening at segmental 
level (eg, the trunk of the apical bronchus of the right upper 
lobe, which is usually sliced in cross section and easily 
identiﬁ  ed on CT scans) with emphysema in some individu-
als (Figure 1). The wall thickening in large or intermediate 
airways provides only a rough estimate of small airways 
disease, whereas air trapping on HRCT in current smokers 
or ex-smokers correlates with the inﬂ  ammatory inﬁ  ltration 
of peripheral airways (Berger et al 2003). Accordingly, 
air-trapping on CT could mirror the peripheral airway 
obstruction, which is hardly detectable with conventional 
lung function tests. However, a “mosaic” pattern represent-
ing small airway disease is difﬁ  cult, if not impossible, to 
identify on HRCT if a background of widespread emphy-
sema co-exists (Aziz et al 2005). In COPD patients, areas of 
decreased attenuation of the lung parenchyma can be seen 
together with bronchiectasis. In this context, the mosaic 
pattern is likely to reﬂ  ect the accompanying obliteration 
observed in small airway disease (Kang et al 1995).
Bronchiectasis in COPD patients has been sparsely 
reported. The presence of bronchiectasis on CT may provide 
a means of identifying those patients with COPD who are at 
risk of more severe disease exacerbations (Figure 2). One 
study reported that 29% of COPD patients who developed 
disease exacerbations displayed bronchiectatic changes on 
HRCT (O’Brien et al 2000). In a study by Patel et al (2004), 
the extent of bronchiectasis in the lower lobes was related to 
colonization by a potential pathogen in the lower airways, 
increased airway inﬂ  ammatory markers, and longer time to 
symptom recovery after exacerbation. However, no correla-
tion was observed with frequency of exacerbations (Patel et al 
2004). It is unclear whether COPD patients with bronchiec-
tasis should be regarded as a speciﬁ  c phenotype or whether 
bronchiectasis simply represents a concomitant disease. It is 
possible that multiple patho-physiologic alterations – including 
damaged muco-ciliary transport, localized or diffuse peripheral 
obliteration of the bronchial tree or lung tissue scarring act in 
concert in COPD – produce the typical structural abnormalities 
seen on HRCT. Longitudinal studies are required in order to 
clarify the signiﬁ  cance of the bronchiectatic structural changes 
observed in COPD, and their inﬂ  uence on the natural history 
of this condition (Patel et al 2004).
The last decade has seen much progress toward under-
standing of the larger airway diseases via MDCT. Small pits 
can be often detected along the inner surfaces of the large 
bronchi, using volumetric thin-section CT (Zompatori et al 
2006). It has been suggested that such pits (or diverticula) 
may correspond to dilated bronchial gland ducts opening into 
the airway lumen (Grenier et al 2004; Zompatori et al 2006). 
Zompatori et al reported that diverticula can be often seen 
in patients with chronic bronchitis (Figure 3) together with 
abnormalities typical of chronic bronchitis, such as erythema, 
mucosal irregularities, secretions, and friability (Zompatori 
et al 2006). Since even physician-conﬁ  rmed self-reported 
Figure 1 Thin-section CT scan of a smoker with chronic cough associated with 
chronic obstructive pulmonary disease. The segmental bronchial walls (white 
arrow) in the upper lobes are thickened. Early centrilobular emphysema is also 
present.
Figure 2 α1-Antitrypsin deﬁ  ciency associated panlobular emphysema. There is a 
generalized decreased attenuation of the lung parenchyma and a striking paucity of 
pulmonary vasculature. Bronchiectasis are more prominent in the left lower lobe 
and coexist with patchy consolidation (probable infection). It is worth keeping in 
mind that panlobular emphysema shows an increased prevalence and extent of long 
lines in comparison to patients with obliterative bronchiolitis.International Journal of COPD 2007:2(3) 304
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diagnosis of chronic bronchitis rarely satisﬁ  es the criteria for 
chronic bronchitis, the evaluation of the bronchial pits might 
support the clinical diagnosis if they reveal (through pathologic-
radiologic correlations) signs of chronic bronchitis.
CT quantiﬁ  cation emphysema
CT has been used to detect and characterize emphysema 
and grade its severity. Emphysema is evident on CT scans 
performed with 5–10 mm thick sections in the vast majority 
of cases. Thinner sections reconstructed by using an edge 
enhancing algorithm (high resolution CT, HRCT) improve 
the deﬁ  nition of emphysematous changes in the lung. On 
the other hand, MDCT allows a volumetric evaluation 
of the chest with 1mm collimation (volumetric HRCT). 
The most prominent features of the MDCT technology 
are represented by an increased speed and post-processing 
algorithms. When using up-to-date scanner technology, 
even patients with severe COPD are able to hold their breath 
both in inspiration and expiration (Zaporozhan et al 2005). 
The HRCT discriminates between various types of emphy-
sema (Figures 1 and 2). In particular, the use of minimum 
intensity projection (MinIP) images allows the detection of 
subtle emphysema (Remy-Jardin et al 1996). Thin-section 
volumetric acquisitions provide an isotropic data set, which 
can be rearranged in any plane. As a result, these multiplanar 
reformations allow to easily evaluating the distribution of the 
emphysematous areas.
Methods for quantifying emphysema on CT include 
visual estimation and automated techniques, both of which 
have their proponents (Desai et al 2006). Both methods dem-
onstrated good correlation with pathological assessment of 
emphysema severity (Bergin et al 1986; Muller et al 1988; 
Kuwano et al 1990; Gevenois et al 1995; Gevenois, De Vuyst 
1996). The extent of the disease may be visually graded 
according to a categorical scale, which can be conﬁ  ned to 
selected levels (eg, three or ﬁ  ve) (Bergin et al 1986; Mishima, 
Itoh et al 1999). A potential drawback of visual estimation 
is measurement of “noise” due to inter-observer variation, 
although observer disagreement in scoring the extent of 
emphysema has not been a major factor in previous stud-
ies (Cleverley et al 2000; Desai et al 2006). The potential 
interobserver variation is balanced by the speed and the 
simplicity of the technique.
The density mask method represents a cornerstone of 
CT lung assessment for emphysema (Muller et al 1988; 
Gevenois, De Vuyst et al 1996). It applies a density threshold 
(HU) below which all voxels are considered to be emphysema 
(Muller et al 1988). Using precise morphometric measure-
ments of resected lung tissue, Bankier et al (1999) showed that 
observers, regardless of their experience, tend to overestimate 
the extent of emphysema on CT, whereas CT densitometry 
correlates better with the morphometric reference. The 
density mask is particularly useful in characterizing mild/
moderate and severe emphysema and has been used in the 
NETT to identify subgroups of patients who show beneﬁ  t 
from lung volume reduction surgery (LVRS) (Fishman et al 
2003). The percentage of emphysema quantiﬁ  ed by density 
mask is also predictive of survival in α1-antitrypsin–induced 
emphysema (Dawkins et al 2003).
With the software available on most MDCT scanners, 
computer-aided recognition and quantiﬁ  cation of emphysema 
is now even faster than human evaluation. In addition, it is 
possible to apply techniques measuring lung density to volu-
metric data. The resolution achieved in thoracic CT allows 
the application of high-precision 3D image analysis tools to 
CT data (Kuhnigk et al 2005) (Figure 4). The analyses allow 
a convenient, regional (lobar or segmental) assessment of CT 
parameters of the lung, such as total volume, mean density, 
pixel index, and emphysema type (Kuhnigk et al 2005). The 
regional distribution of emphysema as it may inﬂ  uence the 
mortality of COPD patients (Martinez et al 2006). Therefore, 
its objective assessment might prove crucial. However, a 
density-masking approach alone is not sufﬁ  cient to accurately 
distinguish between normal and diseased lung, especially in 
the case of early or mixed pathologic processes (Uppaluri et al 
Figure 3 CT coronal reformation of a patient with symptoms of chronic bron-
chitis. Small bronchial diverticula (arrow) seen as outpouchings of the bronchial 
lumen visible along the left main bronchus.International Journal of COPD 2007:2(3) 305
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1997, 1999; Hoffman et al 2006). Further, CT densitometry 
may be inﬂ  uenced by several factors (eg, age, weight, beam 
hardening from adjacent ribs etc.) and calibration must be 
performed in order to obtain reliable densitometry results 
(Shaker et al 2004; Stoel et al 2004; Coxson and Rogers 
2005; Gevenois, Scillia et al 1996). Neither visual nor pure 
densitometric approaches to CT quantiﬁ  cation of emphysema 
are, therefore, perfect.
Beside a pure analysis of the percentage of voxels below 
a certain threshold, CT scan data can be approached by a 
more sophisticated analysis tools. Contiguous emphysema 
areas can be clustered to obtain the volumes for small-
sized, medium-sized, and large-sized emphysematous areas 
(Blechschmidt et al 2001; Zaporozhan et al 2005). The cluster 
distribution was reported to be useful in revealing the pattern 
of progression of emphysema (Mishima, Hirai et al 1999). 
Figure 4 3D rendering of thin-section CT (postero-anterior view) scan with tracheobronchial tree (azure-blue) and both lower lobes (green) and upper lobes (red). Inside 
lobes all pixels of -950 HU or less are highlighted (yellow), identifying areas of emphysema. Image generated using MeVisPULMO software (www.mevis.de). (Courtesy of Jan-
Martin Kuhnigk, Bremen, Germany).International Journal of COPD 2007:2(3) 306
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Furthermore, the cluster analysis could be performed on scans 
obtained by scanners of different manufacturers. Uppaluri 
et al (1997, 1999) examined multiple features of the CT 
images and X-ray attenuation values to describe the lung and 
developed the Adaptive Multiple-Feature Method (AMFM), 
which can assess as many as 22 independent textural features 
from HRCT scans to classify a tissue pattern. This “texture” 
is very sensitive for lung analysis and can distinguish smokers 
from non-smokers in the absence of other disease (Hoffman 
et al 2006). Nonetheless, this technique has not been validated 
with pathological correlation and is limited to the single 
scanner it has been trained for.
CT quantiﬁ  cation of small airways
Several studies conﬁ  rmed that airways smaller than 2 mm in 
internal diameter represent the major site of airway obstruc-
tion in patients with COPD (Hogg et al 2004). The 2 mm 
airways are located between the 4th and the 14th generation 
of tracheobronchial tree branching. Recent histologic evalu-
ation of a large group of cases has shown that airﬂ  ow limita-
tion strongly correlated with severity of the lumen occlusion 
by inﬂ  ammatory exudates and wall thickening of the small 
airways by a repair and remodeling process (Hogg 2006).
A number of CT scoring systems have been developed 
that allow an assessment of the extent and distribution of 
airway abnormalities. Air-trapping is a key finding for 
depicting small airways obstruction on HRCT scans. Berger 
et al (Berger et al 2003) showed that air trapping on HRCT 
in current smokers or ex-smokers correlated with inﬂ  amma-
tory inﬁ  ltration of peripheral airways. The areas of decreased 
attenuation may not be visible on inspiratory CT. A dynamic 
acquisition by MDCT, using low dose over the entire thorax 
during continuous forced expiratory maneuver, provides an 
exhaustive assessment of air-trapping and airway collapse 
(Grenier et al 2002, 2005). Quantiﬁ  cation of air-trapping 
extent is obtained by semiquantitative visual score that is, 
however, not always straightforward in COPD patients. More 
sophisticated approaches to the quantiﬁ  cation of obstructive 
lung diseases include evaluation of texture characteristics of 
the lung parenchyma, which is able to discriminate between 
apparently non-specific areas of decreased attenuation 
(Chabat et al 2003).
It has been shown that the size of the large and intermedi-
ate airways reﬂ  ect airway dimensions in the smaller airways 
(Nakano et al 2005). These data suggest that, in COPD, 
measuring airway dimensions in the larger bronchi, which are 
accurately assessed by CT, can provide an estimate of small 
airway remodeling (Figure 1). There has been considerable 
interest in the development of objective measurements to 
determine airway wall dimensions; this is largely due to 
the interobserver disagreement in the visual interpreta-
tion of bronchial wall thickness on CT scans (Muller and 
Coxson 2002). The most commonly reported method for 
measuring the airway lumen and wall areas relies on the 
‘‘full-width-at-half-maximum’’ (or ‘‘half-max’’) technique, 
in which the inner and outer airway wall boundaries are 
deﬁ  ned as the point corresponding to the half maximal 
intensity of the airway wall voxels (Nakano et al 2000; 
de Jong et al 2005). Using the half-max method, Nakano and 
colleagues (2000) showed that an increased thickness of the 
apical segmental bronchus in the right upper lobe, as assessed 
by HRCT, correlated with the severity of airﬂ  ow obstruction 
and gas trapping (FEV1, FVC, and FEV1/FVC) in smokers 
with COPD independently of the degree of emphysema mea-
sured on the same HRCT scans. However, Nakano, Whithall 
et al (2002) have also shown that the half-max method results 
in very large fractional errors in the measurements of small 
bronchi. Indeed, measurements of airway lumen and wall area 
depends on the lung volume and angle between the airway 
central axis and the plane of section (Grenier et al 2004). 
This has led to efforts to develop alternative computational 
methods to overcome limitations related to the use of two-
dimensional planar data for airway analysis.
The advent of MDCT has changed the approach to 
airways measurements. Hasegawa et al (2006) developed 
a new software, which uses curved multiplanar reforma-
tions for depicting a three-dimensional airway skeleton 
and measures luminal areas of airways and wall areas 
(based on the full width at half-maximum principle). Using 
phantoms, they demonstrated that it is possible to obtain 
accurate short images with an inner diameter as small as 
2 mm and a wall thickness of 1 mm, and that the short 
axis images obtained are precisely perpendicular to the 
long axis even with a sigmoid-shaped phantom (Hasegawa 
et al 2006). The same authors also demonstrated in patients 
with COPD that FEV1 (% predicted) correlates strongly 
with airway luminal area and, to a lesser extent, with 
wall thickening from the third to the sixth generation of 
both apical and basal bronchus, and that the correlation 
coefﬁ  cients improves as airway size decreases (Hasegawa 
et al 2006). Newer airway segmentation methods have 
been also shown to be robust in the presence of mixed 
diseases (including emphysema, ﬁ  brosis and bronchiec-
tasis) and when applied to images acquired using low-
dose scanning protocols (Hoffman et al 2006). These 
methods may also provide reliable comparisons of airway International Journal of COPD 2007:2(3) 307
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dimensions between individuals or in the same individual 
over time (Hoffman et al 2006).
CT functional imaging
Lung structure and function can be linked by CT. The term 
functional imaging is open to two broad interpretations: one 
is the idea that an understanding of functional abnormalities 
can be obtained by correlation with objective quantiﬁ  cation 
of morphological abnormalities seen on detailed images of 
the lung (Hansell 2004). These correlations are complex in 
COPD patients. The chronic airﬂ  ow limitation is attributed to 
the narrowing of the small airway lumen secondary to mor-
phological changes and to a decrease in lung elastic recoil. 
Several studies have shown the interdependence of airway 
remodeling and emphysema in their contribution to the 
degree of airﬂ  ow obstruction (Gurney et al 1992; Gelb et al 
1993; Nakano, Muller et al 2002; Aziz et al 2005). In COPD, 
the extent of centrilobular emphysema is quite variable for a 
given level of airﬂ  ow limitation, conﬁ  rming that the extent of 
emphysema is not the only morphologic abnormality causing 
airﬂ  ow obstruction. In the HRCT scan studies of structure-
function, correlation between the degree of emphysema and 
FEV1 has been extremely variable; usually, correlation coef-
ﬁ  cient (rho) values are in the range of −0.7, indicating that 
only about half of the variability of the population has been 
accounted for (Cosio and Snider 2001). The CT evaluation 
of the airway diseases improves the embracement of those 
functional-structural correlations.
The ratio of inspiratory to expiratory CT density may 
represent an easy index, which allows to evaluate the con-
tribution of small airways (Eda et al 1997). In particular, 
the expiratory scans provide critical insights into the 
relationship between structure and function. Expiratory 
HRCT measurements correlate best with pulmonary func-
tion tests (PFTs), particularly with measures of air trapping 
(O’Donnell et al 2004; Zaporozhan et al 2005). Further, 
O’Donnell et al (2004) showed that the ratio of the mean 
lung density (MLD) on expiration to MLD on inspiration 
(E/I) is more effective in distinguishing smokers with and 
without airﬂ  ow obstruction than inspiratory HRCT, carbon 
monoxide transfer factor (TLco) or carbon monoxide transfer 
coefﬁ  cient (Kco). Interestingly, the same authors showed 
that the sputum inﬂ  ammatory cell count strongly correlated 
with measurements of peripheral airway obstruction and 
gas trapping (RV/TLC ratio), MLD on expiration and the 
E/I ratio; on the other hand, no correlation was observed 
with either inspiratory percentage of emphysema or TLco, 
both indicators of emphysema. Thereby, they speculated 
that increased sputum neutrophil counts is likely to reﬂ  ect 
the more distal neutrophilic inﬂ  ammation that is associated 
with bronchiolitis and/or destruction of peripheral airway 
alveolar attachments (O’Donnell et al 2004).
The anatomical site of the emphysema determines the 
degree of impairment of lung function. This issue has been 
addressed in a number of studies showing that the extent of 
emphysema on HRCT in the upper zones correlates with func-
tional abnormalities less strongly than the extent of emphysema 
in the lower zones (Parr et al 2004). Furthermore, the radial 
distribution of emphysema may have functional consequences. 
Emphysema located in the lung periphery has less effect on 
DLco than more central emphysema (Nakano et al 1999).
While most functional-morphologic correlations between 
extent of emphysema and various functional parameters have 
provided a somehow contradictory array of data, stepwise 
analysis has been usefully applied in an opposite manner. 
Desai et al (2006) constructed a composite physiologic index 
(CPI) against the morphologic extent of disease in order to 
calibrate the quantiﬁ  cation of emphysema using pulmonary 
function tests in isolation. FEV1 and Kco levels were the only 
retained variables by the stepwise technique; interestingly, 
the equation explanatory power was higher when using visual 
score (r2 = 0.57) than when quantiﬁ  cation of emphysema 
was automated (r2 = 0.48). However, it has to be emphasised 
that the composite index does not replace the morphological 
information provided by CT but does add precision to evalu-
ation of functional severity (Desai et al 2006).
In terms of airﬂ  ow limitation secondary to emphysema, 
the contribution of large airways diseases should not be over-
looked. An association between tracheobronchomalacia and 
COPD has been also suggested (Heussel et al 2004), although 
prevalence data are limited. Because tracheobronchomalacia 
escapes detection on routine end-inspiratory imaging studies, 
it is widely considered an under-diagnosed condition. How-
ever, cine MDCT during coughing has been showed to be a 
powerful tool for the diagnosis of tracheomalacia (Boiselle 
et al 2006) (Figure 5). Correlation with clinical symptoms 
may also be helpful in determining the clinical signiﬁ  cance 
of patients who show tracheal collapse between 50% and 
69% during coughing (Boiselle et al 2006) (Figure 5). In 
this regard, it is difﬁ  cult to accurately identify the relative 
contributions of tracheomalacia to airﬂ  ow obstruction.
The second interpretation of functional imaging is based 
on the idea of quantifying speciﬁ  c functional aspects of 
the lungs (both pulmonary ventilation and perfusion) and 
depicting the data pictorially (for example a color-coded map 
of regional ventilation) (Hansell 2004) (Figure 6).International Journal of COPD 2007:2(3) 308
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Ventilation assessed by CT
The technique of Xe-CT was recognised over 30-years ago 
(Foley et al 1978). Stable (non-radioactive) xenon gas has 
a K edge similar to that of iodine and is, therefore, a potent 
X-ray attenuator, which provides good contrast enhance-
ment when used in conjunction with CT scanning. Regional 
ventilation is measured from time course of CT density 
change during a multi-breath wash-in and wash-out of radio-
dense Xe gas (Hoffman and Chon 2005). The enhancement 
due to xenon yields direct assessments of well-ventilated 
versus poorly ventilated lung regions. More recently, Xe has 
been used in an animal experiment involving monochromatic 
synchrotron radiation CT (Bayat et al 2001). By obtaining 
simultaneous images at two different levels, absolute Xe con-
centrations can be calculated via a subtraction mechanism. 
Furthermore, the spatial distribution of Xe concentrations 
in the airspaces, the dynamic of airspace ﬁ  lling as well as 
images of airways with a diameter in the range of 1 mm could 
be obtained (Bayat et al 2001). With the introduction of dual 
energy CT scanners, single-breath Xe (without previous 
unenhanced acquisitions) technique is currently experiencing 
new interest (Figure 6). However, the reliability and clinical 
diagnostic value of these applications needs to be conﬁ  rmed 
in future studies (Johnson et al 2006).
Perfusion assessed by CT
Various approaches for determining pulmonary perfusion 
have been described. After the injection of an iodinated 
contrast material, an ECG-gated dynamic MDCT scanning 
can be performed (Hoffman et al 2006). Lung segmentation 
and post-processing analysis are used to determine the 
mean transit time and pulmonary blood ﬂ  ow normalized 
to regional air content (Schoepf et al 2004) (Figure 6). 
These measurements may be potentially used for detecting 
the early micro-vascular changes in the lung parenchyma 
associated with emphysema. Furthermore, Hoffman and 
co-workers (2006) have recently proposed an attractive hy-
pothesis regarding the pathogenesis of emphysema. Regional 
alterations in blood ﬂ  ow parameters may not only serve as 
an early marker of inﬂ  ammatory processes but may also 
cause the pathologic process itself, leading to emphysema 
in a subset of smokers (not all smokers have emphysema) 
(Hoffman et al 2006). An inherent loss of the ability to blunt 
regional hypoxic pulmonary vasoconstriction (HPV), when 
the regional hypoxia is due to inﬂ  ammatory events, may set 
the individual up for the evolution of the tissue destruction, 
which is a hallmark of emphysema (Hoffman et al 2006). 
Accordingly, Remy-Jardin and colleagues (2002) have dem-
onstrated that, in a subset of smokers who show decline over 
time in pulmonary function tests, this decline correlates with 
the development of emphysema in regions showing signs 
of ground glass and micro-nodules at an earlier time point. 
However, not all smokers with ground glass and micro-
nodules developed emphysema in these regions but these 
subjects also did not show a decline in pulmonary function 
tests (Remy-Jardin et al 2002). Although shunting blood 
away from regions of poor ventilation is commonly believed 
Figure 5 Tracheomalacia elicited by coughing maneuver in 65-year-old man. CT 
scan shows near complete collapse of airway lumen, consistent with tracheomala-
cia. Advanced centrilobular and paraseptal emphysema also coexist.
Figure 6 Example of a reconstruction from dual-energy CT in a patient presenting 
with an exacerbation of chronic obstructive pulmonary disease. Axial image with 
superimposed color-coded iodine distribution shows the lung perfusion and a 
defect (blue-black) caused by an occluding embolus in the right descending artery 
(arrow). (Courtesy of Christian Fink, MD, Munich, Germany).International Journal of COPD 2007:2(3) 309
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to be an advantageous and protective mechanism, when the 
poor ventilation is secondary to inﬂ  ammatory processes (ie, 
micronodules and ground glass found by Remy-Jardin and 
colleagues 2002), maintaining an adequate blood supply to 
that area can be beneﬁ  cial for the resolution of the inﬂ  am-
mation (Hoffman et al 2006).
Functional evaluation of the lung 
with MRI
Magnetic resonance imaging of the lung is notoriously 
challenging (Kauczor and Kreitner 1999). The low proton 
density of lung parenchyma usually leads to poor signal using 
standard MRI techniques. Susceptibility artifacts caused 
by multiple air-tissue interfaces, and motion artifacts due 
to cardiac and respiratory function (Kauczor and Kreitner 
1999) further contribute in degrading image quality. Recent 
technical advances in MR pulse sequences and hardware 
design have improved the visualization of lung parenchyma. 
The possibility to administer contrast agents via inhalation or 
venous injection has further enhanced the potential capabili-
ties of MRI for the clinical evaluation of lung morphology 
and function (Hatabu et al 1999; Kauczor and Kreitner 1999; 
Biederer et al 2003).
A considerable contribution in the understanding of 
structure-function relationships in the lung has been brought 
by the use of non-radioactive noble gas isotopes in MRI 
(ie, 3-He and 129-Xe) (Albert et al 1994; Kauczor et al 1996; 
Salerno et al 2001; van Beek et al 2004). Although the ﬁ  rst 
hyperpolarized gas MR images of the lung were obtained 
with 129-Xe (Albert et al 1994), much of the recent clinical 
research has been focused on 3-He MRI. Following the expo-
sure to polarized laser light, 3-He increases its spin polarization 
and can be used as inhaled MR contrast agent. The signal of 
hyperpolarized 3-He is detected by MR coils tuned to 
resonance frequency of the gas. The signal enhancement 
produced by hyperpolarized 3-He is measured with high 
temporal and spatial resolution three-dimensional imaging 
techniques. This enables the dynamic assessment of gas ﬂ  ow 
into the airways (ie, spirometry) and pulmonary airspace (ie, 
ventilation) (Gast et al 2002). Within the same protocol, 3-He 
density images can be obtained, demonstrating the homoge-
neity of ventilation. Diffusion weighted imaging are also used 
to measure the degree of restriction of the Brownian motion 
of 3-He atoms, reﬂ  ecting lung microstructure (Morbach et al 
2005). Additionally, as the decay of 3-He hyperpolariza-
tion is dependent on the alveolar concentration of oxygen, 
the local intrapulmonary PO2 can be measured (Wild et al 
2005), providing indirect assessment of pulmonary perfusion, 
ventilation/perfusion ratio and oxygen uptake. Potential 
applications of this imaging tool have been shown in recent 
studies (Ley et al 2004; Woodhouse et al 2005; Woods 
et al 2006). In the functional characterization of patients 
with COPD, in smokers, in asthmatics and in a subject with 
allergies, ventilation defects can be accurately depicted. 
Diffusion weighted images demonstrate quantitatively the 
emphysematous changes in the pulmonary structure. Good 
agreement with lung function tests in the characterization 
of emphysema (ie, hyperinﬂ  ation, large and small airway 
disease) has been demonstrated (Ley et al 2004).
Similarly to hyperpolarized 3-He, molecular oxygen 
can be used as an inhaled MR contrast agent (Lofﬂ  er et al 
2000; Mai et al 2000). In oxygen-enhanced MRI, however, 
the signal intensity of the lung increases by different mecha-
nism. Following 100%-oxygen inhalation, the paramagnetic 
effect of this gas on proton spins of blood water causes a 
T1-shortening effect in the lung. Signal enhancement is gen-
erated after molecular oxygen diffuses through the alveolar-
capillary barrier and dissolves into the capillary bloodstream. 
Because diffusion is part of this process, oxygen-enhanced 
MRI may be used as a method to estimate the local transfer 
of oxygen in the lung. The use of standard proton MR equip-
ment also makes oxygen-enhanced MRI less expensive and 
more keen to a clinical application. However, some technical 
difﬁ  culties essentially related to the weak paramagnetic 
effect of oxygen have delayed the assessment of the clinical 
relevance of this imaging modality. In fact, the inhalation 
of 100% oxygen produces only a limited signal intensity 
change in the lung. To demonstrate this effect, artiﬁ  cial signal 
variations caused by cardiac pulsatility and respiration must 
be minimized and post-processing of imaging data is also 
required. For the same reason, the total imaging time may 
suffer from the need to acquire numerous images during room 
air and 100% oxygen inhalation. Additionally, the process 
causing the signal intensity increase in the lung is still under 
investigation. Over the years, clinical applications of oxygen-
enhanced MRI have been successfully demonstrated (Ohno 
et al 2001, 2005). The development of new MR protocols 
for multislice image acquisition have also increased the 
potential applicability of this technique in a clinical setting 
(Dietrich et al 2005).
The administration of blood contrast media has been 
primarily used in lung MRI to demonstrate the pulmonary 
vessels. Dynamic contrast-enhanced MR angiography 
of the lung has been indicated as a potential alternative, 
with comparable accuracy, to digital subtraction and CT 
angiography (Pedersen et al 2006). The implementation International Journal of COPD 2007:2(3) 310
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of newer techniques for data acquisition, such as parallel 
imaging and view sharing, on clinical systems have increased 
the time resolution of the MRI protocols (Fink et al 2004). 
Combined with larger anatomical coverage and improved 
spatial resolution, such three-dimensional techniques can 
easily and accurately visualize the transit of the contrast 
bolus in the pulmonary vasculature. Because the temporal 
resolution can be increased to less than 1 second, dynamic 
three-dimensional contrast-enhanced MRI is very sensitive 
to the capillary transit of the contrast medium (ie, perfusion). 
The signal of the lung during dynamic contrast-enhanced 
MRI can be also analyzed mathematically to obtain quan-
titative parameters, such as pulmonary blood ﬂ  ow, blood 
volume and mean transit time (Fink et al 2004; Ohno et al 
2004). Quantitative maps of lung perfusion, obtained by those 
parameters, have been compared with perfusion scintigraphy, 
and the results of such studies look promising (Yilmaz et al 
2005; Molinari et al 2006). In patients with emphysema, the 
typical diffuse abnormalities of the peripheral pulmonary 
vasculature have been demonstrated (Morino et al 2006). 
Because quantiﬁ  cation of pulmonary blood ﬂ  ow is also 
potentially feasible, dynamic contrast-enhanced MRI has 
been proposed for the evaluation and the monitoring of the 
severity of the disease (Sergiacomi et al 2003; Morino et al 
2006). In patients with extensive emphysematous changes in 
the lung, however, the quantitative assessment of perfusion 
may be inﬂ  uenced by the increased air content and reduced 
proton density of lung parenchyma (Molinari et al 2006). 
The feasibility of perfusion MRI in COPD patients has been 
demonstrated (Amundsen et al 2000). Clinical applications, 
such as the estimation of residual lung function in patients 
undergoing surgery, using perfusion MRI have been also 
proposed (Johkoh et al 2000).
Finally, MRI has been also used for the assessment 
of lung volumes and respiratory mechanics (Qanadli et al 
1999; Suga et al 2000; Plathow et al 2004; Voorhees et al 
2005; Chu et al 2006; Swift et al 2007). Continuous dynamic 
acquisition of MR images without contrast administration 
has gained considerable temporal resolution to accurately 
depict the movements of the chest wall and diaphragm 
during the respiratory cycle (Plathow et al 2004). Quantita-
tive parameters derived from MRI measurements have been 
compared to pulmonary functional tests assessing static and 
dynamic lung volumes (Plathow et al 2004; Swift et al 2007). 
Dynamic MRI during respiration has been also proposed to 
assess noninvasively and directly the impaired respiratory 
mechanics associated with abnormal ventilation in pulmo-
nary emphysema (Suga et al 2000).
Conclusion
Advances in CT technology suggest that this technique can 
be used in big-time studies in COPD. On the other hand, 
MDCT imaging of the lung is sufﬁ  ciently developed to justify 
its use for assessing both the natural history of emphysema 
and the impact of surgical and medical interventions. We 
believe that MDCT may potentially represent the gold 
standard against which MRI quantitative measures can be 
reﬁ  ned. In addition, it seems reasonable to hypothesize that 
the clinical use of lung MRI will further increase in the near 
future, improving the evaluation of the functional damage 
associated with COPD.
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